The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
incred equities lowers nifty target upgrades pharmaceutical sector outlook
InCred Equities has revised its Nifty target down by 3% to 25,327 points, citing a challenging macroeconomic environment and delayed RBI rate cuts. The brokerage upgraded the pharmaceutical sector to "overweight," highlighting positive revisions for stocks like Cipla and Alkem Laboratories, while sectors such as commodities and FMCG faced downgrades. Despite an 8% decline in the Nifty-50 index since mid-September, improved consumer sentiment during the festive season is expected to boost retail demand.
Ipca Laboratories upgraded to accumulate with target price of Rs 1700
Ipca Laboratories reported a Q2 EBITDA of Rs 4.5 billion, falling 5% short of estimates, yet management upheld a 9% revenue growth forecast while raising margin guidance for FY25 by 100 bps. The stock is now rated as ACCUMULATE with a target price of Rs 1,700, reflecting a 27% EPS CAGR over FY24-27E.
Ipca Laboratories reports strong quarterly growth and positive market outlook
Ipca Laboratories reported quarterly revenues of Rs. 2,355 crore, a 16% year-on-year increase, with a profit after tax of Rs. 245 crore, up 39%. The company’s EBITDA rose to Rs. 441 crore, reflecting a 22% growth. Strategic investments and regulatory approvals are expected to drive future growth, with a target price of Rs. 1765.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.